BMY
Bristol Myers SquibbPrevious close
62.48
Change
+1.09 / +1.78%
P/E (TTM) ?
13.8
Market Cap
$128B
1M
+0.13%
S&P 500 −0.91% over same period
Volume / Avg Volume
12.7M / 10.6M
1.20× average
Latest earnings analysisFY2026 Q2Reported 2026-07-30
Bristol Myers Squibb Q2 2026: revenue up 6.0%, EPS $1.62, guidance raised
Bristol Myers Squibb beat on both lines and raised full-year revenue and EPS guidance, so this quarter reads Bullish on execution rather than on one-off gains. Read it in three layers: $12.97 billion of revenue grew 6.0%, gross margin slipped to 71.3%, and GAAP EPS of $1.62 came in against a $1.6038 consensus.
Read the full analysis →Revenue$12.97BYoY +5.70%
EPS (non-GAAP)$2.04Beatest. $1.60
Next-quarter revenue guidance$49.50B ±1%YoY +281.60%
Next-day move+0.69%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-30 | $13.0B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-30 | $11.5B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-05 | $48.2B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-30 | $12.2B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-31 | $12.3B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-24 | $11.2B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 27 of its 5-year rangeCheap
5-year range 12.5 – 19.0 · Median 16.3
Last 4 quarters: $0 in buybacks + $5.1B in dividends, 3.98% of market cap combined
P/E (TTM)
13.8
P/B
5.7
P/S
2.6
Dividend Yield
4.58%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.2% on average on the first trading day after, rising 4 times
Most recent +0.69%
Volatility & Correlation
1-year beta 0.17 · Correlation with S&P 500 0.08Low beta
Annualized volatility 28% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.44MNet selling $0.44M
- 09-09Massacesi CristianEVP,Chief Med Offr,Head of DevSell$0.40M6,249 shares · Avg price 64.57
- 08-25Holzer Phil MSVP and ControllerSell$0.03M500 shares · Avg price 67.50
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 13.07 | +6.9% | 68.3% | 2.16 | 1.05 |
| FY2026 Q2 | 12.97 | +5.7% | 71.3% | 3.32 | 1.62 |
| FY2026 Q1 | 11.49 | +2.6% | 70.2% | 2.68 | 1.31 |
| FY2025 Q4 | 12.50 | +1.3% | 67.2% | 1.09 | 0.54 |
| FY2025 Q3 | 12.22 | +2.8% | 71.9% | 2.20 | 1.08 |
| FY2025 Q2 | 12.27 | +0.6% | 72.5% | 1.31 | 0.64 |
| FY2025 Q1 | 11.20 | −5.6% | 72.9% | 2.46 | 1.20 |
| FY2024 Q4 | 12.34 | +7.5% | 61.0% | 0.07 | 0.05 |
| FY2024 Q3 | 11.89 | +8.4% | 75.1% | 1.21 | 0.60 |
| FY2024 Q2 | 12.20 | +8.7% | 73.2% | 1.68 | 0.83 |
| FY2024 Q1 | 11.87 | +4.7% | 75.3% | -11.91 | -5.89 |
| FY2023 Q4 | 11.48 | +0.6% | 76.1% | 1.76 | 0.87 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| BMY | 13.8 | +6.9% | 68.3% | +0.13% | Bullish |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |